Skip to main content

A phase 1b, randomized, double-blind, placebo-controlled, multiple-ascending dose study to investigate the safety, tolerability and pharmacokinetics of DSTA4637A in patients with Staphylococcus Aureus Bacteremia receiving standard-of-care antibiotics

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Infectious Diseases

Awarded By

Genentech, Inc.

Start Date

October 19, 2017

End Date

November 14, 2020
 

Administered By

Medicine, Infectious Diseases

Awarded By

Genentech, Inc.

Start Date

October 19, 2017

End Date

November 14, 2020